@CynAq @bbbhltz @megane_kun Apparently, being a leftist in France + using encryption to protect privacy = Terrorist
@zeitverschreib @nm @vegan yeah but that's a comment not a post, right ?
UEFA Champions League final
@wesley Lukaku won't have it :/
La beauté du Fediverse est, entre autres, dans l’interopérabilité des outils.
Se passer de Twitter ? Avec Mastodon. De Youtube ? Avec Peertube.
Oui, mais si vous ne produisez jamais de vidéos mais voulez vous abonner à un diffuseur ? Faut-il créer un compte Peertube ?
Non, depuis Mastodon, vous pouvez simplement suivre la chaîne Peertube de votre intérêt.
Par exemple, je publie mes conférences sur le compte @oneploumshow auquel vous pouvez vous abonner sans jamais quitter Masto !
@colburn Rooting for Inter coz who wants to see oil clubs winning the CL.
« Hausse des taux de marge : les entreprises françaises préfèrent augmenter leur rentabilité plutôt que les salaires. » https://www.liberation.fr/economie/hausse-des-taux-de-marge-les-entreprises-francaises-preferent-augmenter-leur-rentabilite-plutot-que-les-salaires-20230609_2I5TW7WRANDZTGXEK6MQTLEZCY/
Gearing up to start a large new project and I'm seeking recommendations for an application that I can use to highlight/make notes on web pages / pdfs that are then saved and backed up in a way I can usefully review them later.
Ideally the app would be self-hosted, and also support highlighting/note taking on a not-exactly-modern Android device.
Invidious: "YouTube legal team contacted us" https://beehaw.org/post/474448
We’re looking for African researchers keen to represent their community on our editorial board.
Does this sound like you? Apply to join our Board of Reviewing Editors! https://elifesciences.org/inside-elife/5b024d5b/elife-latest-applications-open-for-new-reviewing-editors-in-africa?utm_source=mastodon&utm_medium=social&utm_campaign=organic
If two-year-old Mohammad al-Tamimi was named Eric instead, would his killing by Israeli soldiers have been treated differently in the international media?
SCOTUS rules agains Amgen, 9-0. An important decision because Amgen wanted to enforce a patent on any monoclonal against a particular target (the PCSK9 receptor), which would have set a terrible precedent.
"This case does not involve those antibody-specific patents. Instead, it involves much broader patents Amgen obtained, which cover every antibody that binds to the same sweet spot and works the same way, a class that includes potentially millions of antibodies."
"Compared with other bacteria, #Salmonella, a facultative anaerobe, has higher motility and accumulation in tumors and a special advantage in targeting tumor quiescence, possibly via the chemoreceptors of Salmonella"
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(23)00189-1
Tunisian 🇹🇳 Pharmacist 💊 Romanista 🐺
I'll toot about whatever